Management of poor-prognosis testicular germ cell tumors.

about

Unusual presentation of mixed germ cell tumour from testis in a 45-year-old man.Case report: Extragonadal mixed germ cell tumor in the thigh.

P2860

Q40339245-D97DB72A-3638-4570-8132-7C8995AB4F54 Q47136741-E44ED32A-417F-4A1B-A0F6-7F217D7B0032

P2860

Management of poor-prognosis testicular germ cell tumors.

Item

http://www.wikidata.org/entity/Q40810851

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Management of poor-prognosis testicular germ cell tumors.

@en

type

Item

label

Management of poor-prognosis testicular germ cell tumors.

@en

prefLabel

Management of poor-prognosis testicular germ cell tumors.

@en

P1476

Management of poor-prognosis testicular germ cell tumors

@en

P2093

Andrew J Stephenson

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2009

Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group. European Organization for Research and Treatment of Ca

Guidelines on testicular cancer.

Survival of non-seminomatous germ cell cancer patients according to the IGCC classification: An update based on meta-analysis.

Viable malignant germ cell tumor in the postchemotherapy retroperitoneal lymph node dissection specimen: can it be predicted using clinical parameters?

A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial.

Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups.

High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors.

Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.

European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II.

P304

108-114

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/0970-1591.61228

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kiranpreet K Khurana

Timothy D Gilligan

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20535296

http://www.w3.org/2001/XMLSchema#string

P932

2878420

http://www.w3.org/2001/XMLSchema#string

Management of poor-prognosis testicular germ cell tumors.

about

P2860

P2860

Management of poor-prognosis testicular germ cell tumors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932